Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

GUEST CHIEF MEDICAL EDITOR’S PAGE

Lower Extremity Techniques


Rapidly evolving endovascular tech- injury impact which treatment tools and techniques are
nologies and techniques have dramat- selected for a procedure.
ically expanded the treatment options Retrograde tibiopedal access may be the single-most
for patients with peripheral artery important interventional technique for reducing tech-
disease (PAD) in recent years. Today’s nical failure rates in peripheral intervention, and in this
practitioners, whether veteran or nov- issue, Katherine M. Reitz, MD, and Rabih Chaer, MD,
ice, must maintain constant vigilance describe their strategy and technique when employing
to these advancements in vascular retrograde tibiopedal access for infrapopliteal lesions,
care in order to provide the most up-to-date options including discussion of patient evaluation, preinterven-
for the complex and heterogeneous disease processes tion planning, and device selection.
encountered in everyday practice. Luis Mariano Palena, MD; Larry J. Diaz-Sandoval, MD;
Each patient we treat has unique comorbidities and Elisa Piccolo, MD; and Marco Manzi, MD, introduce
cardiovascular risk factors that influence treatment precise retrograde stenting of the ostium of the super-
choice, but also has a unique lesion characteristics, ficial femoral artery for complex femoropopliteal occlu-
including patterns of multivessel and/or multilevel dis- sions, also known as the PRESTO technique. Along with
ease, that impact device and technique efficacy. The het- a step-by-step review of the technique, the authors dis-
erogeneity of this population requires a wide-ranging skill cuss pre- and postoperative imaging, patient selection,
set, as well as the humility to embrace new lessons from devices, and complication management.
the experiences of our colleagues, whether entirely new Closing out our lower extremity feature is a piece on
approaches or the minor tweaks that make a consider- pedal acceleration time (PAT) by Jill Sommerset, RVT;
able difference. The constant technologic advancement Miguel Montero-Baker, MD; Mary Costantino, MD;
in this field and the ongoing accumulation of clinical Riyad Karmy-Jones, MD; and Desarom Teso, MD. In this
data ensure there is always something new to learn. article, we learn about a proper protocol for incorporat-
This edition of Endovascular Today asks a group ing PAT into periprocedural planning, on-table inter-
of leading interventionalists for their approaches to vention, and immediate postprocedural assessment,
patient workup, therapy selection, preprocedural tips with the goal of monitoring hemodynamic response to
and tricks, pitfall avoidance, and supporting data. therapies and predicting wound healing potential.
Edel Mendoza, MD, and John H. Rundback, MD, In our monthly featured interview column, we chat-
begin our lower extremity coverage with a look at PAD ted with Manj S. Gohel, MD, about involving patients
patients with complex chronic total occlusions. From in clinical decision-making, aftereffects of the EVRA
patient workup and preprocedural imaging to proce- trial and other concerns with venous leg ulcer care, and
dural approach and postoperative care, they give us a needs in deep venous occlusive disease.
technical guide to their management approach for these As we all know, there is no “one approach fits all”
complex occlusions, with a focus on tibial interventions. solution to peripheral vascular disease. Based on our
Our next technical walkthrough comes from own training and experience, not every technique is
Christopher J. Agrusa, MD, who shares his treatment right for us, nor the patient. Knowing what not to do in
algorithm and discusses how directional atherectomy a given situation may be the biggest key to success, one
(DA) and drug-coated balloon angioplasty can be used that only comes with experience—whether direct or
in combination to treat complex femoropopliteal ath- learned from colleagues.
erosclerotic disease, as well as insights from the clinical We appreciate the authors’ graciousness in sharing
trial landscape for DA. their techniques, as well as their emphasis on under-
For patients with life-limiting claudication or standing the importance of optimal medical therapy
chronic limb-threatening ischemia, the femoropop- and the appropriate applications of alternative options,
liteal segment tends to be the most common site including open repair. We hope the lessons they share
of plaque-related significant disease burden. Kumar in this edition are helpful in your continued pursuit of
Madassery, MD; Shaan Haider, BS; and Akhilesh excellence in the care of your patients. n
Pillai, BS, present tips for attaining patency and ensur-
ing success in this vascular bed, including consideration Brian G. DeRubertis, MD, FACS
of how specific types of plaque burden and vessel wall Guest Chief Medical Editor

4 ENDOVASCULAR TODAY SEPTEMBER 2023 VOL. 22, NO. 9

You might also like